| TNNI3K (HH498) | MLK | TKL | 4yff | B | B | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6063 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | A | B | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9800 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | D | C | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9795 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | D | A | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6072 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | B | A | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9802 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | D | A | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9792 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | C | A | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6070 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | A | C | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9798 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | B | B | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9794 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | C | B | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6067 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | D | B | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6064 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | C | A | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6069 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | A | A | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9791 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | A | A | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6068 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | D | B | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6074 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | C | A | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9799 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | C | B | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9793 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | C | B | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6073 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | A | B | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6071 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | D | A | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6066 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | B | C | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9797 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | A | A | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6059 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | B | A | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6065 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | D | B | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9801 | 0.48 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | B | A | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6061 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 6b5j | C | C | n-methyl-3-[(6-{[4-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide | Human | 9796 | 0.48 | |
| CDK2 | CDK | CMGC | 1oiu | C | B | 3-(6-cyclohexylmethoxy-9h-purin-2-ylamino)-benzenesulfonamide | Human | 4049 | 0.41 | |
| PIK3CG (p110g) | PIK | Atypical | 4wwp | A | | n-{(1s)-1-[8-chloro-2-(2-methylpyridin-3-yl)quinolin-3-yl]ethyl}-9h-purin-6-amine | Human | 9200 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | A | B | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6062 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | B | B | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6060 | 1.00 | |
| CDK2 | CDK | CMGC | 2exm | A | | n-(3-methylbut-2-en-1-yl)-9h-purin-6-amine | Human | 4055 | 0.47 | |
| CDK2 | CDK | CMGC | 1oiu | A | B | 3-(6-cyclohexylmethoxy-9h-purin-2-ylamino)-benzenesulfonamide | Human | 4556 | 0.41 | |
| CDK2 | CDK | CMGC | 1oiu | A | A | 3-(6-cyclohexylmethoxy-9h-purin-2-ylamino)-benzenesulfonamide | Human | 4110 | 0.41 | |
| CDK2 | CDK | CMGC | 1oiu | C | A | 3-(6-cyclohexylmethoxy-9h-purin-2-ylamino)-benzenesulfonamide | Human | 4524 | 0.41 | |
| MKNK2 (MNK2) | MAPKAPK | CAMK | 6cje | A | | 4-[(9h-purin-6-yl)amino]benzamide | Human | 9884 | 0.50 | |
| MAPK1 (Erk2) | MAPK | CMGC | 4qp4 | A | B | n-cyclohexyl-9h-purin-6-amine | Human | 6075 | 0.45 | |
| MAPK1 (Erk2) | MAPK | CMGC | 4qp1 | A | | n-benzyl-9h-purin-6-amine | Human | 6092 | 0.42 | |
| MAPK1 (Erk2) | MAPK | CMGC | 4qp4 | B | B | n-cyclohexyl-9h-purin-6-amine | Human | 6083 | 0.45 | |
| CDK2 | CDK | CMGC | 5anj | A | | n-(9h-purin-6-yl)thiophene-2-carboxamide | Human | 6541 | 0.40 | |
| BRAF | RAF | TKL | 4yht | B | | 3-[(5-chloro-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6443 | 0.41 | |
| BRAF | RAF | TKL | 4yht | A | | 3-[(5-chloro-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6442 | 0.41 | |
| CDK2 | CDK | CMGC | 5ani | A | | 6-chloro-9h-purine | Human | 6539 | 0.40 | |
| MAPK1 (Erk2) | MAPK | CMGC | 4qp1 | B | | n-benzyl-9h-purin-6-amine | Human | 6080 | 0.42 | |
| MAPK1 (Erk2) | MAPK | CMGC | 4qp4 | B | A | n-cyclohexyl-9h-purin-6-amine | Human | 6086 | 0.45 | |
| MAPK1 (Erk2) | MAPK | CMGC | 4qp4 | A | A | n-cyclohexyl-9h-purin-6-amine | Human | 6088 | 0.45 | |
